During a visit to Aurobindo Pharma Malta Ltd, the President of the European Parliament, Roberta Metsola reiterated her commitment to make EU funds more accessible to businesses, especially in Malta and Gozo. 

President Metsola said, “The role that companies such as Aurobindo play in our Union is crucial to ensure that citizens receive top-quality products that meet the standards they deserve”. Access to funding was another topic of discussion during President Metsola’s visit, where she mentioned that access to EU funding opportunities is instrumental for companies such as Aurobindo to maximise their potential, and invest in their workforce and in state-of-the-art equipment. She referred to the company’s expansion of its laboratories focusing on testing of medication used for chemotherapy.


“We all know someone who has been diagnosed with cancer. The fight against cancer is our common fight and the European Parliament is committed to beating this disease, with the final destination being a Europe without cancer.

Venugopalan Muralidharan, President Europe Formulations of Aurobindo and Jonathan Farrugia, Managing Director of Aurobindo Malta said that they were honoured to welcome the President of the European Parliament at the state-of-the-art Aurobindo facility in Malta.  “As one of the leading global generics companies, with the largest and most sophisticated analytical laboratory on the Maltese Islands, analysing sterile and non-sterile medicinal products including high-potency products, as well as, batch release, warehousing and distribution, we are always keeping ourselves abreast with the latest regulatory updates, to ensure that we offer our clients the best pharmaceutical products. Welcoming President Metsola at our laboratories and offices in Malta gave us the opportunity to discuss matters important to us and our sector, while getting a better understanding of how we can benefit from the opportunities offered by the European Union, in terms of funding”.